Stock listing

Genmab A/s

Selected listing: GMAB · OMXCOP · DKK · DK

Genmab A/s (Copenhagen:GMAB), Health Technology. Latest release Oct 3, 2026: Genmab A/S : Announces Rinatabart Sesutecan (Rina-S) Phase 2 RAINFOLTM-01 Results…

GMAB:OMXCOPDKKDKUpdated October 2, 2026

Ticker: Copenhagen:GMAB
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: Copenhagen
Currency: DKK

About Genmab A/s

Genmab A/S is a public company listed on the Danish stock market under the ticker GMAB. Genmab focuses on developing innovative antibody therapies for the treatment of cancer and other diseases.

Latest news from Genmab A/s

Genmab A/S : Announces Rinatabart Sesutecan (Rina-S) Phase 2 RAINFOLTM-01 Results Demonstrated Durable and Clinically Meaningful Responses in Patients with Platinum-Resistant Ovarian Cancer

October 3, 2026

Genmab Announces Rinatabart Sesutecan (Rina-S®) Phase 2 RAINFOL™-01 Results Demonstrated Durable and Clinically Meaningful Responses in Patients with Platinum-Resistant Ovarian Cancer

October 3, 2026

Notice to Convene an Extraordinary General Meeting of Genmab A/S

September 8, 2026

Genmab A/S : Interim Report for the First Half of 2026

August 6, 2026

Genmab Announces Financial Results for the First Half of 2026

August 6, 2026

All Genmab A/s news →

Events

Replays

Genmab A/S (GMAB) Q2 2026 Earnings Call
Thu, Aug 06, 2026 · 12:00 PM ET
Watch
Genmab A/S (GMAB) Q1 2026 Earnings Call
Thu, May 07, 2026 · 12:00 PM ET
Watch
Genmab A/S (GMAB) Q4 2025 Earnings Call
Tue, Feb 17, 2026 · 12:00 PM ET
Watch

Research Genmab A/s

Genmab A/s company profile

View the public company page for Genmab A/s on 6ix.

Genmab A/s news

Read company news and market updates connected to Genmab A/s.

Genmab A/s investor events

Find investor webinars, events, and replay context for Genmab A/s.